StockData

Mosaic ImmunoEngineering Inc. (CPMV) stock

CPMVOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30
$0.33+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.41MP/E –Yield –

Earnings

Mosaic ImmunoEngineering's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Mosaic ImmunoEngineering's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q1 FY2011ended Aug 31, 2010Oct 13, 2010after the close–––Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Mosaic ImmunoEngineering has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Mosaic ImmunoEngineering puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Mosaic ImmunoEngineering filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?